Goldman Sachs upgraded Incyte (NASDAQ: INCY) from Sell to Neutral with a price target of $62.00 (from $32.00).Analyst Navdeep Singh ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE